EP-1678: Practice Guidelines skin care advice for patients undergoing radical external beam megavoltage radiotherapy  by Harris, R. et al.
3rd ESTRO Forum 2015                                                                                                                                         S919 
 
 
 
 
 
Conclusions: Our data suggest that SCRT followed by delayed 
surgery (1 week) is well tolerated. However, beyond the 2-3 
week toxicity increases and may require medical treatment 
at the hospital. SCRT and delayed surgery (4-8 weeks after 
radiotherapy) may improve outcomes, but the acute toxicity 
of these patients should be carefully evaluated. 
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Purpose/Objective: Skin reactions from external beam 
radiotherapy are one of the most common side-effects from 
treatment (1, 2), and may cause distress to some patients, 
and in certain cases may be a factor which can limit radiation 
dose and treatment schedules. Megavoltage linear 
accelerators with skin sparing capabilities have significantly 
reduced the severity of reactions from radiotherapy; however 
accelerated radiation dose schedules with concurrent 
chemotherapy, and the use of biological agents such as 
epidermal growth factor receptor (EGFR) inhibitors, have led 
to an increase in certain skin reactions (3). Significant skin 
reactions are also seen in patients receiving high doses to 
large fields, in patients where there are folds of skin (for 
example inframmary fold, groin, axilla) and patients 
receiving radiotherapy to the head and neck region (4, 5). 
Yet despite changes in radiotherapy practice and numerous 
published skin care guidelines (6, 7)) patient skin care 
appears to have changed little over the years, with no 
consensus amongst centres using different skin care 
regimens, product use and approaches. 
Materials and Methods: A Guideline Development Group have 
reviewed the current evidence to assist radiographers, 
radiotherapy nurses, and the wider radiotherapy workforce, 
to give the optimal skin care advice to patients undergoing 
radical external beam megavoltage radiotherapy. Although it 
is unlikely that radiation reactions can be completely 
prevented, the current driver is to delay the onset and 
minimise the severity of a skin reaction, to reduce symptom 
related discomfort, and prevent further complications. 
Results: The recommendation from the guidance document is 
to standardise skin care education of all staff caring for 
patients receiving radiotherapy by dissemination of the 
guidance using a variety of educational methods. 
Conclusions: Standardise assessment tools across 
departments which are objective and consistent. Consider 
the evidence on current products and start new high quality 
trials to investigate interventions for dry or moist 
desquamation enabling a more consistent approach for 
patients receiving radiotherapy and inform radiotherapy skin 
care guidelines. 
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Purpose/Objective: Given that radiotherapy is usually an 
outpatient treatment, the nurse has to provide the patient 
and the carer the necessary information and support to 
resolve the process positively and to jointly elaborate a plan 
for cures adapted to the various situations, which the patient 
will be undergoing.  
The carer is usually someone from the family, a neighbour or 
a friend without specific training, who will become key to the 
link between the patient and the nurse. 
In this paper, we would like to measure the degree of 
satisfaction of the task of the carer during the treatment and 
also to receive feedback for the response they have received 
from the nurse. 
To improve the healing of the patient. 
 To detect early problems encountered related to 
the patient's illness. 
